News

Deal Announcements

Aureon Biosciences Nets $8 Million Venture Capital Debt

Friday, June 3, 2011 5:58:00 AM PDT | VentureDeal Staff
   Yonkers, New York  --  Medical diagnostics company Aureon Biosciences has secured $8 million in venture capital debt financing.

Aureon has developed technology to provide personalized test results for prostate cancer.

Investors in the financing were not disclosed. The company is still seeking $2 million in additional financing, according to the SEC regulatory filing.

Email Page  Email Page | Print Page Print Page

Free Trial

Want unlimited access to the complete database with thousands of technology companies, VCs and transactions for only $25 per month?

Start your Free 14 Day Trial now – no obligation or credit card required.

Free 14 day trial. No Obligation. Click to Register.
Venturedeal Twitter Venturedeal Facebook Venturedeal Linkedin


PCI - Level1